Skip to main content

KalVista Pharmaceuticals, Inc.

KALVDelisted Jun 11, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001348911

KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.

13F holders, Q1 2025

Institutional positions in KalVista Pharmaceuticals, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
128
−1 vs. Q4 2024
Shares held
54.9M
−189.1K (−0.3%) vs. Q4 2024
Total value
$633.7M
+$166.9M (+35.8%) vs. Q4 2024
New holders
23
45 more added
Sold out
24
35 more reduced

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting KALV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 128 institutions
Q1 2021: 117 institutionsQ2 2021: 110 institutionsQ3 2021: 105 institutionsQ4 2021: 97 institutionsQ1 2022: 89 institutionsQ2 2022: 91 institutionsQ3 2022: 94 institutionsQ4 2022: 91 institutionsQ1 2023: 88 institutionsQ2 2023: 94 institutionsQ3 2023: 101 institutionsQ4 2023: 93 institutionsQ1 2024: 129 institutionsQ2 2024: 119 institutionsQ3 2024: 122 institutionsQ4 2024: 130 institutionsQ1 2025: 128 institutionsQ2 2025: 140 institutionsQ3 2025: 145 institutionsQ4 2025: 162 institutionsQ1 2026: 184 institutionsQ2 2026: 1 institution
Value heldQ1 2025: $633.7M
Q1 2021: $605.1MQ2 2021: $582.7MQ3 2021: $408.2MQ4 2021: $314.6MQ1 2022: $363.9MQ2 2022: $238.7MQ3 2022: $372.0MQ4 2022: $236.2MQ1 2023: $265.0MQ2 2023: $310.1MQ3 2023: $349.2MQ4 2023: $453.0MQ1 2024: $557.2MQ2 2024: $568.2MQ3 2024: $561.0MQ4 2024: $467.4MQ1 2025: $633.7MQ2 2025: $615.5MQ3 2025: $714.0MQ4 2025: $1.08BQ1 2026: $1.39BQ2 2026: $189
Institutions holding KALV and their total value by quarter
QuarterHoldersValue
Q2 20261$189
Q1 2026184$1.39B
Q4 2025162$1.08B
Q3 2025145$714.0M
Q2 2025140$615.5M
Q1 2025128$633.7M
Q4 2024130$467.4M
Q3 2024122$561.0M
Q2 2024119$568.2M
Q1 2024129$557.2M
Q4 202393$453.0M
Q3 2023101$349.2M
Q2 202394$310.1M
Q1 202388$265.0M
Q4 202291$236.2M
Q3 202294$372.0M
Q2 202291$238.7M
Q1 202289$363.9M
Q4 202197$314.6M
Q3 2021105$408.2M
Q2 2021110$582.7M
Q1 2021117$605.1M

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding KalVista Pharmaceuticals, Inc.; share changes are against Q4 2024.

Institutions holding KALV in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
StemPoint Capital LP386,837$4.46M1.43%−605,966−61.0%Reduced
Northern Trust Corp387,562$4.47M0.00%+21,392+5.8%Added
JPMorgan Chase & Co402,504$4.64M0.00%+381,244+1,793.2%Added
Allostery Investments LP458,302$5.29M7.63%−20,798−4.3%Reduced
UBS Group AG507,703$5.86M0.00%+133,072+35.5%Added
Schonfeld Strategic Advisors LLC581,746$6.71M0.05%+581,746New
Emerald Mutual Fund Advisers Trust608,213$7.02M0.50%+58,525+10.6%Added
Dimensional Fund Advisors LP645,993$7.46M0.00%−50,044−7.2%Reduced
DAFNA Capital Management LLC752,359$8.68M2.46%−59,319−7.3%Reduced
Parkman Healthcare Partners LLC753,752$8.70M1.03%+753,752New
Schroder Investment Management Group868,011$10.4M0.01%+62,566+7.8%Added
Emerald Advisers, LLC898,190$10.4M0.47%+62,140+7.4%Added
Geode Capital Management, LLC915,241$10.6M0.00%+92,889+11.3%Added
Great Point Partners LLC1,014,367$11.7M6.36%−772,636−43.2%Reduced
State Street Corp1,093,643$12.6M0.00%−297,220−21.4%Reduced
Octagon Capital Advisors LP1,370,000$15.8M3.44%00.0%Unchanged
Woodline Partners LP1,617,469$18.7M0.12%+329,068+25.5%Added
Silverarc Capital Management, LLC1,698,984$19.6M4.10%+1,086,811+177.5%Added
Vanguard Group Inc2,298,598$26.5M0.00%+43,355+1.9%Added
BlackRock, Inc.3,151,735$36.4M0.00%+287,739+10.0%Added
Capital World Investors3,177,587$36.7M0.01%−196,477−5.8%Reduced
Vestal Point Capital, LP4,751,292$54.8M3.92%−18,708−0.4%Reduced
Frazier Life Sciences Management, L.P.4,887,867$56.4M2.58%00.0%Unchanged
Suvretta Capital Management, LLC4,913,012$56.7M2.29%00.0%Unchanged
Tang Capital Management LLC4,941,798$57.0M3.15%+47,951+1.0%Added
VR Adviser, LLC6,703,985$77.4M6.58%+454,254+7.3%Added
Nuveen, LLC37,321––+37,321New
Capital Performance Advisors LLP3,845––+3,845New
Boxer Capital Management, LLC0$00.00%−1,590,000−100.0%Sold out
Readystate Asset Management LP0$00.00%−315,700−100.0%Sold out
Citadel Advisors LLC0$00.00%−136,493−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−126,132−100.0%Sold out
Zimmer Partners, LP0$00.00%−95,704−100.0%Sold out
Jane Street Group, LLC0$00.00%−69,397−100.0%Sold out
Simplex Trading, LLC0$00.00%−35,125−100.0%Sold out
XTX Topco Ltd0$00.00%−31,573−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−22,822−100.0%Sold out
Advisor Group Holdings, Inc.0$00.00%−20,804−100.0%Sold out
Group One Trading, L.P.0$00.00%−20,227−100.0%Sold out
Quest Partners LLC0$00.00%−17,700−100.0%Sold out
SG Americas Securities, LLC0$00.00%−14,508−100.0%Sold out
Two Sigma Investments, LP0$00.00%−13,463−100.0%Sold out
Nebula Research & Development LLC0$00.00%−11,579−100.0%Sold out
EntryPoint Capital, LLC0$00.00%−11,509−100.0%Sold out
Syon Capital LLC0$00.00%−10,993−100.0%Sold out
Profund Advisors LLC0$00.00%−10,762−100.0%Sold out
Graham Capital Management, L.P.0$00.00%−10,479−100.0%Sold out
Algert Global LLC0$00.00%−10,360−100.0%Sold out
American Century Companies Inc0$00.00%−10,072−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−5,188−100.0%Sold out
Zurcher Kantonalbank (Zurich Cantonalbank)0$00.00%−1,164−100.0%Sold out
R Squared Ltd0$00.00%−110−100.0%Sold out
Nuveen Asset Management, LLC––––Not filed